Abbott, Biogen report MS drug reduced relapse rate – Boston.com
Abbott, Biogen report MS drug reduced relapse rateBoston.comBiogen Idec and Abbott Laboratories said Sunday a mid-stage study of their multiple sclerosis medicine daclizumab showed that the experimental drug worked better than placebo at preventing rel…